Mulligan Mobilization With Movement for Acute Lateral Ankle Sprains
Unravelling the Specificity of Mulligan Mobilization With Movement on Acute Lateral Ankle Sprains: A Randomized Controlled Trial
2 other identifiers
interventional
110
1 country
1
Brief Summary
This randomized controlled trial evaluates the effects and clinical specificity of Mulligan Mobilization With Movement (MWM) in adults with grade I or II lateral ankle sprains occurring less than 6 weeks before enrollment. The primary study population consists of participants enrolled within 2 weeks of the index lateral ankle sprain. Participants with an injury occurring between 2 and less than 6 weeks before enrollment are also eligible. Approximately 110 participants will be allocated to a Mulligan MWM intervention group or a control group receiving usual-care rehabilitation without Mulligan treatment. In the intervention group, three MWM techniques targeting the inferior tibiofibular, talocrural, and cubometatarsal joints are tested in a randomized order and adapted according to the participant's immediate pain-free response. Treatment includes up to six sessions provided twice weekly. Clinical outcomes are assessed at baseline, 3 weeks, and 3 months. The primary outcomes are ankle dorsiflexion range of motion, ankle joint arthrokinematics, and pain during weight-bearing dorsiflexion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 24, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 30, 2027
September 30, 2026
September 1, 2026
2 years
September 24, 2026
September 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Ankle Dorsiflexion Range of Motion Measured With the Weight-Bearing Lunge Test
Ankle dorsiflexion range of motion is measured in centimeters (hallux-to-wall distance) and degrees (tibial inclination) using the Weight-Bearing Lunge Test performed against a wall. Higher values indicate greater weight-bearing ankle dorsiflexion.
Throughout the entire study, during approximately 24 months
Posterior talar glide range of motion
Posterior talar glide range of motion is assessed using the Posterior Talar Glide Test (tibial inclination in degrees). Higher values indicate greater posterior talar glide range of motion.
Throughout the entire study, during approximately 24 months
Patient-Reported Sensations During the Weight-Bearing Lunge Test
Patient-reported sensations are assessed using the Weight-Bearing Lunge Test sensory-mapping process. During the end-range Weight-Bearing Lunge Test position, participants report the type(s) and anatomical localization(s) of the sensation(s) perceived.
Throughout the entire study, during approximately 24 months
Secondary Outcomes (14)
Static Postural Control During Single-Leg Stance
Throughout the entire study, during approximately 24 months
Dynamic postural control using the Modified Y-Balance Test
Throughout the entire study, during approximately 24 months
Eversion strength
Throughout the entire study, during approximately 24 months
Inversion strength
Throughout the entire study, during approximately 24 months
Dorsiflexion strength
Throughout the entire study, during approximately 24 months
- +9 more secondary outcomes
Study Arms (2)
Mulligan Mobilization With Movement
EXPERIMENTALParticipants receive Mulligan Mobilization With Movement for lateral ankle sprain. Three MWM techniques targeting the inferior tibiofibular, talocrural, and cubometatarsal joints are tested according to a randomized sequence. Treatment is adapted according to the participant's immediate pain-free response. Treatment is provided for up to six 15-minute sessions, twice weekly, and may be stopped earlier if symptoms resolve.
Usual-Care Rehabilitation
ACTIVE COMPARATORParticipants receive usual-care rehabilitation for lateral ankle sprain without Mulligan Concept treatment. The rehabilitation provided by the treating physiotherapist is documented during the study.
Interventions
A physiotherapist trained in the Mulligan Concept applies Mobilization With Movement while the participant actively performs ankle dorsiflexion. Three techniques targeting the inferior tibiofibular, talocrural, and cubometatarsal joints are tested according to a randomized sequence. The intervention is performed without pain and is evaluated for an immediate response. According to the protocol, an immediate clinically relevant response is defined as a 2-point improvement in pain on the numerical rating scale or an improvement greater than 1.9 cm in ankle dorsiflexion measured with the Weight-Bearing Lunge Test. If the response criterion is not met, the next MWM technique in the randomized sequence is tested. Up to six treatment sessions are provided twice weekly.
Participants receive traditional rehabilitation for lateral ankle sprain without Mulligan Mobilization With Movement. Rehabilitation is adapted to the participant's clinical presentation and is documented by the treating physiotherapist.
Eligibility Criteria
You may qualify if:
- Grade I or II lateral ankle sprain Index lateral ankle sprain occurring less than 6 weeks before enrollment Age 18 years or older No fracture associated with the index lateral ankle sprain No immobilization in a plaster cast Able to provide written informed consent
You may not qualify if:
- Grade III lateral ankle sprain Index lateral ankle sprain occurring 6 weeks or more before enrollment Additional lower-limb musculoskeletal disorder or injury incompatible with study participation Neurological disorder Severe hypertension Renal disease Cardiorespiratory disorder Sickle cell disease Arterial calcification Varicose veins Current anticoagulant treatment Current risk of or history of deep-vein thrombosis Fragile skin Previous surgery affecting sports performance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FYKI Sports
Gistoux, Chaumont-Gistoux, 1325, Belgium
Related Publications (4)
Powden CJ, Hoch JM, Hoch MC. Reliability and minimal detectable change of the weight-bearing lunge test: A systematic review. Man Ther. 2015 Aug;20(4):524-32. doi: 10.1016/j.math.2015.01.004. Epub 2015 Jan 29.
PMID: 25704110BACKGROUNDPicot B, Lopes R, Rauline G, Fourchet F, Hardy A. Development and Validation of the Ankle-GO Score for Discriminating and Predicting Return-to-Sport Outcomes After Lateral Ankle Sprain. Sports Health. 2024 Jan-Feb;16(1):47-57. doi: 10.1177/19417381231183647. Epub 2023 Jul 11.
PMID: 37434508BACKGROUNDDelahunt E, Bleakley CM, Bossard DS, Caulfield BM, Docherty CL, Doherty C, Fourchet F, Fong DT, Hertel J, Hiller CE, Kaminski TW, McKeon PO, Refshauge KM, Remus A, Verhagen E, Vicenzino BT, Wikstrom EA, Gribble PA. Clinical assessment of acute lateral ankle sprain injuries (ROAST): 2019 consensus statement and recommendations of the International Ankle Consortium. Br J Sports Med. 2018 Oct;52(20):1304-1310. doi: 10.1136/bjsports-2017-098885. Epub 2018 Jun 9.
PMID: 29886432BACKGROUNDNguyen AP, Pitance L, Mahaudens P, Detrembleur C, David Y, Hall T, Hidalgo B. Effects of Mulligan Mobilization with Movement in Subacute Lateral Ankle Sprains: A Pragmatic Randomized Trial. J Man Manip Ther. 2021 Dec;29(6):341-352. doi: 10.1080/10669817.2021.1889165. Epub 2021 Feb 26.
PMID: 33634747RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anh Phong Nguyen, PhD
CIRRIS ULaval
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors are blinded to treatment allocation. Participants are not informed whether they are assigned to the Mulligan Mobilization With Movement intervention group or the control group. Outcome assessors performing the clinical measurements are blinded to treatment allocation and do not participate in treatment delivery. Treating physiotherapists are not blinded because they deliver the allocated intervention. They have access to the clinical assessment results to guide the individualized background rehabilitation provided to participants in both groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2026
First Posted
September 30, 2026
Study Start
January 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 30, 2027
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not planned to be made publicly available or routinely shared with external researchers. Study data will be handled in accordance with the study protocol, informed consent, applicable data protection regulations, and UCLouvain institutional requirements.